In a clinical trial, the first patient has received a single dose of a new human immunodeficiency virus (HIV) gene editing therapy, researchers at the Lewis Katz School of Medicine at Temple University and Excision BioTherapeutics, Inc have reported.
In a collaborative effort, the researchers are currently running a phase 1/2 clinical trial to evaluate the safety and efficacy of their therapy, called EBT-101, which is based on gene editing technology known as CRISPR. ...
Posted by snytiger6Hundreds of love letters between two gay men during WWII ...
Posted by snytiger6All for love and ...
Posted by snytiger6Being gay is not a sin ...
Posted by snytiger6Bigot Bird ...
Posted by snytiger6Pride is important ...
Posted by snytiger6Coming out ...
Posted by snytiger6Larissa awakens Christmas morning to find ...
Posted by CliffordCook([iowafaithleadercoalition.
Posted by snytiger6Victoria's Secret model, huh ...
Posted by snytiger6I come in peace ...
Posted by snytiger6You need to find peace with your uniqueness...
Posted by snytiger6The only choice made was to be myself...
Posted by snytiger6The day you graduate from...
Posted by snytiger6Trust me. There is no other man...
Posted by snytiger6The bible belt...
Posted by snytiger6Condiment come out...